Accelerates wound healing through growth factor modulation Stimulates angiogenesis (formation of new blood vessels) to injured areas Promotes fibroblast activity and collagen formation Protects endothelial function and blood flow Reduces systemic and local inflammation without NSAIDs or corticosteroids Heals tendon-to-bone junctions and muscle strains that are notoriously slow to regenerate BPC-157 improves functional recovery by increasing VEGF expression, enhancing angiogenesis, and accelerating fibroblast migration and collagen deposition. Pevec et al., Journal of Orthopaedic Research While research on humans is still developing, preclinical studies across muscle, tendon, ligament, nerve, and gut tissues have shown consistent healing properties in animal modelswith many athletes and rehab practitioners reporting comparable real-world results
So they have it all in black and white, but we can put that link
Medication works perfectly Super easy and expected results Works great
What is not disputed is that the thicket made it economically rational for biosimilar developers to settle rather than litigate: challenging 130+ patents in BPCIA proceedings would cost more than accepting a licensing arrangement
The effect on kidney health was unrelated to changes in body weight